KalVista Pharmaceuticals, Inc. short interest in 2025
In 2025, KalVista Pharmaceuticals, Inc.'s disclosed short interest ran from 15.35% of shares outstanding on 15 Jan 2025 to 33.48% on 31 Dec 2025, a change of +18.13 percentage points. The year's high was 33.48% on 31 Dec 2025 and its low 11.21% on 28 Feb 2025, averaging 19.08% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 28.62 days on 15 Jan 2025. Full history: KalVista Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 15.35% (15 Jan 2025)
- End of year
- 33.48% (31 Dec 2025)
- Change
- +18.13 pp
- High
- 33.48% (31 Dec 2025)
- Low
- 11.21% (28 Feb 2025)
- Average
- 19.08%
- Highest days to cover
- 28.62 (15 Jan 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 15.35% | 28.62 | |
| 31 Jan 2025 | 14.42% | 23.90 | |
| 14 Feb 2025 | 11.80% | 18.37 | |
| 28 Feb 2025 | 11.21% | 9.32 | |
| 14 Mar 2025 | 11.74% | 8.79 | 10-Q filed, results (8-K) |
| 31 Mar 2025 | 11.78% | 10.67 | |
| 15 Apr 2025 | 12.49% | 7.41 | |
| 30 Apr 2025 | 11.80% | 12.26 | |
| 15 May 2025 | 12.29% | 12.26 | |
| 30 May 2025 | 12.51% | 12.61 | |
| 13 Jun 2025 | 12.58% | 9.34 | |
| 30 Jun 2025 | 17.01% | 5.43 | |
| 15 Jul 2025 | 18.52% | 3.52 | 10-K filed, results (8-K) |
| 31 Jul 2025 | 20.13% | 9.18 | |
| 15 Aug 2025 | 20.09% | 14.33 | |
| 29 Aug 2025 | 20.90% | 18.45 | |
| 15 Sep 2025 | 22.09% | 7.84 | 10-Q filed, results (8-K) |
| 30 Sep 2025 | 25.15% | 9.01 | |
| 15 Oct 2025 | 28.70% | 11.08 | |
| 31 Oct 2025 | 26.38% | 12.70 | |
| 14 Nov 2025 | 28.61% | 10.36 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 28.55% | 10.01 | |
| 15 Dec 2025 | 30.46% | 9.44 | |
| 31 Dec 2025 | 33.48% | 18.10 |
See also: KalVista Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.